Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ensysce Biosciences and Quotient Sciences Announce a Partnership on the Development and Clinical Testing of Ensysce's PF614-MPAR, a Novel Opioid Designed to Prevent Abuse and Overdose
Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC) (OTC PINK: ENSCW), a clinical-stage biotech company […]
ObvioHealth Welcomes Scott Dixon as Newest Chief Commercial Officer
ObvioHealth, a leading global virtual research organization (VRO) delivering end-to-end decentralized clinical trials, today announces Scott […]
NuraLogix Researchers Announce AI Models That Can Predict Blood Biomarker Risk
Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed […]
EndoQuest Robotics Announces Installation of the First Endoluminal Surgical System to Advance the Clinical and Procedural Development of the ELS System at Brigham and Women's Hospital in Boston, Massachusetts
ENDOQUEST Robotics today announced that the company’s proprietary Endoluminal Surgical (ELS) System will be installed […]
Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer
Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The […]
Digital Rehabilitation Platform Neurofenix Completes $7 Million Series A to Transform Stroke and Brain Injury Recovery
Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in […]
IVX Health Announces Opening of New Infusion Centers in Connecticut
IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple […]
Castle Creek Biosciences Announces Publication of Preclinical Study for Potential In Vivo Gene Therapy in Nature Communications
Castle Creek Biosciences announced publication of a preclinical study that found that its experimental in vivo gene […]
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the […]
Swissmedic Authorizes Moderna’s Omicron-targeting Bivalent Booster Candidate, mRNA-1273.214
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more